ProMIS Neurosciences, Inc. (PMN)
8.755
-0.34
(-3.79%)
USD |
NASDAQ |
Dec 11, 16:00
8.51
-0.24
(-2.80%)
After-Hours: 06:58
ProMIS Neurosciences Free Cash Flow: -27.36M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Oncolytics Biotech, Inc. | -18.79M |
| Aurinia Pharmaceuticals, Inc. | 120.39M |
| Edesa Biotech, Inc. | -6.650M |
| Lexaria Bioscience Corp. | -10.55M |
| Xenon Pharmaceuticals, Inc. | -253.05M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -10.18M |
| Cash from Financing (Quarterly) | 21.26M |
| Free Cash Flow Per Share (Quarterly) | -0.2085 |
| Free Cash Flow to Equity (Quarterly) | -10.18M |
| Free Cash Flow to Firm (Quarterly) | -10.18M |
| Free Cash Flow Yield | -8.26% |